Ashland (ASH) Misses Q3 EPS by 20c, Misses on Revenue; Offers FY25 Revenue Guidance

Go back to Ashland (ASH) Misses Q3 EPS by 20c, Misses on Revenue; Offers FY25 Revenue Guidance

Ashland reports third quarter fiscal 2025 results and narrows full-year outlook range

July 29, 2025 5:01 PM EDT

Sales of $463 million, down 15 percent from the prior-year quarterPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC), Nutraceuticals and Avoca portfolio optimization initiatives (collectively, Portfolio Optimization) reduced overall sales by approximately $53 million or 10 percent versus the prior-year quarter. Excluding these initiatives, sales declined five percentLoss from continuing operations of $719 million, or $(15.70) per diluted share, primarily reflecting a non-cash goodwill impairment charge of $706 millionAdjusted Income from Continuing Operations Excluding... More